Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Accenture
Novartis
Healthtrust
Argus Health
AstraZeneca
Chinese Patent Office
Daiichi Sankyo
Julphar
Moodys

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075860

« Back to Dashboard

NDA 075860 describes DESONIDE, which is a drug marketed by G And W Labs Inc, Glenmark Pharms, Perrigo New York, Taro, Fougera Pharms, Taro Pharm, Teligent Pharma Inc, Glenmark Pharms Ltd, and Hi-tech Pharmacal, and is included in thirteen NDAs. It is available from ten suppliers. Additional details are available on the DESONIDE profile page.

The generic ingredient in DESONIDE is desonide. There are thirty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the desonide profile page.
Summary for 075860
Tradename:DESONIDE
Applicant:Fougera Pharms
Ingredient:desonide
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Pharmacology for NDA: 075860
Medical Subject Heading (MeSH) Categories for 075860
Suppliers and Packaging for NDA: 075860
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DESONIDE desonide LOTION;TOPICAL 075860 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0310 N 0168-0310-02
DESONIDE desonide LOTION;TOPICAL 075860 ANDA E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. 0168-0310 N 0168-0310-04

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:LOTION;TOPICALStrength0.05%
Approval Date:Mar 19, 2002TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
UBS
Queensland Health
Teva
Colorcon
Harvard Business School
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot